nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Tamoxifen—pancreatic cancer	0.0827	0.119	CbGbCtD
Efavirenz—CYP2B6—Irinotecan—pancreatic cancer	0.0635	0.0917	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—pancreatic cancer	0.061	0.0881	CbGbCtD
Efavirenz—CYP2C19—Tamoxifen—pancreatic cancer	0.0526	0.0759	CbGbCtD
Efavirenz—CYP1A2—Tamoxifen—pancreatic cancer	0.0485	0.0701	CbGbCtD
Efavirenz—CYP2C9—Tamoxifen—pancreatic cancer	0.0437	0.0631	CbGbCtD
Efavirenz—CYP1A2—Erlotinib—pancreatic cancer	0.0412	0.0596	CbGbCtD
Efavirenz—CYP2D6—Tamoxifen—pancreatic cancer	0.04	0.0577	CbGbCtD
Efavirenz—CYP1A2—Fluorouracil—pancreatic cancer	0.0357	0.0516	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—pancreatic cancer	0.0347	0.0501	CbGbCtD
Efavirenz—CYP2D6—Erlotinib—pancreatic cancer	0.034	0.0491	CbGbCtD
Efavirenz—CYP2C9—Fluorouracil—pancreatic cancer	0.0322	0.0465	CbGbCtD
Efavirenz—CYP3A4—Tamoxifen—pancreatic cancer	0.0254	0.0367	CbGbCtD
Efavirenz—CYP3A4—Erlotinib—pancreatic cancer	0.0216	0.0312	CbGbCtD
Efavirenz—CYP3A4—Irinotecan—pancreatic cancer	0.0195	0.0282	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—pancreatic cancer	0.0168	0.0242	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—pancreatic cancer	0.0143	0.0207	CbGbCtD
Efavirenz—CYP3A4—Sunitinib—pancreatic cancer	0.0142	0.0206	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—pancreatic cancer	0.0107	0.0154	CbGbCtD
Efavirenz—Hypersensitivity—Irinotecan—pancreatic cancer	0.000177	0.000574	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—pancreatic cancer	0.000176	0.000573	CcSEcCtD
Efavirenz—Convulsion—Docetaxel—pancreatic cancer	0.000176	0.000572	CcSEcCtD
Efavirenz—Hypertension—Docetaxel—pancreatic cancer	0.000175	0.00057	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—pancreatic cancer	0.000175	0.00057	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—pancreatic cancer	0.000175	0.00057	CcSEcCtD
Efavirenz—Infestation—Epirubicin—pancreatic cancer	0.000175	0.00057	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000174	0.000565	CcSEcCtD
Efavirenz—Chest pain—Docetaxel—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Efavirenz—Arthralgia—Docetaxel—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Efavirenz—Myalgia—Docetaxel—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Efavirenz—Nausea—Sunitinib—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—pancreatic cancer	0.000172	0.00056	CcSEcCtD
Efavirenz—Asthenia—Irinotecan—pancreatic cancer	0.000172	0.000559	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000172	0.000558	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000172	0.000558	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—pancreatic cancer	0.000171	0.000555	CcSEcCtD
Efavirenz—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000169	0.00055	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—pancreatic cancer	0.000169	0.00055	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000169	0.00055	CcSEcCtD
Efavirenz—Sweating—Epirubicin—pancreatic cancer	0.000168	0.000546	CcSEcCtD
Efavirenz—Asthenia—Gemcitabine—pancreatic cancer	0.000168	0.000545	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—pancreatic cancer	0.000167	0.000543	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—pancreatic cancer	0.000167	0.000543	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000166	0.00054	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000166	0.000539	CcSEcCtD
Efavirenz—Pruritus—Gemcitabine—pancreatic cancer	0.000165	0.000537	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—pancreatic cancer	0.000165	0.000535	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000164	0.000533	CcSEcCtD
Efavirenz—Diarrhoea—Irinotecan—pancreatic cancer	0.000164	0.000533	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—pancreatic cancer	0.000163	0.00053	CcSEcCtD
Efavirenz—Shock—Docetaxel—pancreatic cancer	0.000163	0.00053	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—pancreatic cancer	0.000163	0.000528	CcSEcCtD
Efavirenz—Pruritus—Fluorouracil—pancreatic cancer	0.000163	0.000528	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000162	0.000527	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—pancreatic cancer	0.000162	0.000527	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—pancreatic cancer	0.000162	0.000527	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—pancreatic cancer	0.000162	0.000527	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—pancreatic cancer	0.000162	0.000526	CcSEcCtD
Efavirenz—Skin disorder—Docetaxel—pancreatic cancer	0.000161	0.000523	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000161	0.000523	CcSEcCtD
Efavirenz—Diarrhoea—Gemcitabine—pancreatic cancer	0.00016	0.000519	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—pancreatic cancer	0.000159	0.000518	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000159	0.000517	CcSEcCtD
Efavirenz—Dizziness—Irinotecan—pancreatic cancer	0.000159	0.000515	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—pancreatic cancer	0.000158	0.000514	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—pancreatic cancer	0.000158	0.000514	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—pancreatic cancer	0.000158	0.000513	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—pancreatic cancer	0.000157	0.000511	CcSEcCtD
Efavirenz—Diarrhoea—Fluorouracil—pancreatic cancer	0.000157	0.000511	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000157	0.000509	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—pancreatic cancer	0.000156	0.000505	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000155	0.000505	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—pancreatic cancer	0.000155	0.000504	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—pancreatic cancer	0.000155	0.000503	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000155	0.000503	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—pancreatic cancer	0.000154	0.000501	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000153	0.000499	CcSEcCtD
Efavirenz—Vomiting—Irinotecan—pancreatic cancer	0.000153	0.000496	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—pancreatic cancer	0.000152	0.000495	CcSEcCtD
Efavirenz—Dizziness—Fluorouracil—pancreatic cancer	0.000152	0.000494	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—pancreatic cancer	0.000152	0.000493	CcSEcCtD
Efavirenz—Rash—Irinotecan—pancreatic cancer	0.000151	0.000491	CcSEcCtD
Efavirenz—Dermatitis—Irinotecan—pancreatic cancer	0.000151	0.000491	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000151	0.000491	CcSEcCtD
Efavirenz—Headache—Irinotecan—pancreatic cancer	0.00015	0.000488	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—pancreatic cancer	0.00015	0.000487	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—pancreatic cancer	0.000149	0.000484	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—pancreatic cancer	0.000149	0.000484	CcSEcCtD
Efavirenz—Vomiting—Gemcitabine—pancreatic cancer	0.000149	0.000483	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—pancreatic cancer	0.000148	0.00048	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—pancreatic cancer	0.000147	0.000479	CcSEcCtD
Efavirenz—Rash—Gemcitabine—pancreatic cancer	0.000147	0.000479	CcSEcCtD
Efavirenz—Dermatitis—Gemcitabine—pancreatic cancer	0.000147	0.000478	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—pancreatic cancer	0.000147	0.000478	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—pancreatic cancer	0.000147	0.000477	CcSEcCtD
Efavirenz—Headache—Gemcitabine—pancreatic cancer	0.000146	0.000476	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—pancreatic cancer	0.000146	0.000475	CcSEcCtD
Efavirenz—Flushing—Epirubicin—pancreatic cancer	0.000146	0.000475	CcSEcCtD
Efavirenz—Vomiting—Fluorouracil—pancreatic cancer	0.000146	0.000475	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—pancreatic cancer	0.000146	0.000474	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—pancreatic cancer	0.000146	0.000474	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—pancreatic cancer	0.000146	0.000473	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000145	0.000471	CcSEcCtD
Efavirenz—Rash—Fluorouracil—pancreatic cancer	0.000145	0.000471	CcSEcCtD
Efavirenz—Dermatitis—Fluorouracil—pancreatic cancer	0.000145	0.00047	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—pancreatic cancer	0.000144	0.000468	CcSEcCtD
Efavirenz—Headache—Fluorouracil—pancreatic cancer	0.000144	0.000468	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000144	0.000467	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000143	0.000466	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000143	0.000465	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000143	0.000465	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—pancreatic cancer	0.000143	0.000464	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—pancreatic cancer	0.000143	0.000464	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—pancreatic cancer	0.000143	0.000464	CcSEcCtD
Efavirenz—Nausea—Irinotecan—pancreatic cancer	0.000142	0.000463	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—pancreatic cancer	0.000142	0.000462	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000142	0.000461	CcSEcCtD
Efavirenz—Constipation—Docetaxel—pancreatic cancer	0.000142	0.000461	CcSEcCtD
Efavirenz—Pain—Docetaxel—pancreatic cancer	0.000142	0.000461	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—pancreatic cancer	0.000141	0.000457	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—pancreatic cancer	0.00014	0.000456	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—pancreatic cancer	0.000139	0.000452	CcSEcCtD
Efavirenz—Nausea—Gemcitabine—pancreatic cancer	0.000139	0.000451	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000138	0.000447	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—pancreatic cancer	0.000137	0.000445	CcSEcCtD
Efavirenz—Erythema—Epirubicin—pancreatic cancer	0.000137	0.000445	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—pancreatic cancer	0.000137	0.000444	CcSEcCtD
Efavirenz—Nausea—Fluorouracil—pancreatic cancer	0.000136	0.000443	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—pancreatic cancer	0.000136	0.000442	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—pancreatic cancer	0.000136	0.000441	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000136	0.000441	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000135	0.000439	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—pancreatic cancer	0.000135	0.000439	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—pancreatic cancer	0.000135	0.000439	CcSEcCtD
Efavirenz—Tension—Epirubicin—pancreatic cancer	0.000134	0.000437	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—pancreatic cancer	0.000134	0.000436	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—pancreatic cancer	0.000133	0.000432	CcSEcCtD
Efavirenz—Back pain—Epirubicin—pancreatic cancer	0.000133	0.000431	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—pancreatic cancer	0.000132	0.000429	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—pancreatic cancer	0.000132	0.000427	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000131	0.000427	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—pancreatic cancer	0.000131	0.000426	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—pancreatic cancer	0.000131	0.000426	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—pancreatic cancer	0.00013	0.000423	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—pancreatic cancer	0.000129	0.00042	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—pancreatic cancer	0.000129	0.000418	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000127	0.000413	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—pancreatic cancer	0.000127	0.000412	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—pancreatic cancer	0.000127	0.000412	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—pancreatic cancer	0.000127	0.000412	CcSEcCtD
Efavirenz—Agitation—Epirubicin—pancreatic cancer	0.000126	0.000409	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—pancreatic cancer	0.000125	0.000406	CcSEcCtD
Efavirenz—Tension—Doxorubicin—pancreatic cancer	0.000124	0.000404	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—pancreatic cancer	0.000124	0.000403	CcSEcCtD
Efavirenz—Malaise—Epirubicin—pancreatic cancer	0.000124	0.000402	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—pancreatic cancer	0.000123	0.0004	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—pancreatic cancer	0.000123	0.0004	CcSEcCtD
Efavirenz—Syncope—Epirubicin—pancreatic cancer	0.000123	0.000399	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—pancreatic cancer	0.000123	0.000399	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—pancreatic cancer	0.000122	0.000397	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—pancreatic cancer	0.000121	0.000393	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—pancreatic cancer	0.00012	0.000391	CcSEcCtD
Efavirenz—Cough—Epirubicin—pancreatic cancer	0.00012	0.000389	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—pancreatic cancer	0.000119	0.000388	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—pancreatic cancer	0.000119	0.000387	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—pancreatic cancer	0.000119	0.000386	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—pancreatic cancer	0.000118	0.000384	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000118	0.000382	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—pancreatic cancer	0.000117	0.000381	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—pancreatic cancer	0.000117	0.000381	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—pancreatic cancer	0.000117	0.000379	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—pancreatic cancer	0.000117	0.000379	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—pancreatic cancer	0.000117	0.000379	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—pancreatic cancer	0.000117	0.000379	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—pancreatic cancer	0.000116	0.000378	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000116	0.000376	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—pancreatic cancer	0.000115	0.000375	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—pancreatic cancer	0.000114	0.000372	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—pancreatic cancer	0.000114	0.000371	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—pancreatic cancer	0.000114	0.00037	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—pancreatic cancer	0.000114	0.000369	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—pancreatic cancer	0.000113	0.000369	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—pancreatic cancer	0.000113	0.000366	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—pancreatic cancer	0.000112	0.000364	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000111	0.000362	CcSEcCtD
Efavirenz—Cough—Doxorubicin—pancreatic cancer	0.000111	0.00036	CcSEcCtD
Efavirenz—Shock—Epirubicin—pancreatic cancer	0.00011	0.000358	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—pancreatic cancer	0.00011	0.000357	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—pancreatic cancer	0.00011	0.000356	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—pancreatic cancer	0.00011	0.000356	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00011	0.000356	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—pancreatic cancer	0.000109	0.000356	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—pancreatic cancer	0.000109	0.000355	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—pancreatic cancer	0.000109	0.000353	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000108	0.000351	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—pancreatic cancer	0.000108	0.000351	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—pancreatic cancer	0.000108	0.000351	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—pancreatic cancer	0.000108	0.000351	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—pancreatic cancer	0.000108	0.00035	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000107	0.000348	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—pancreatic cancer	0.000107	0.000347	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—pancreatic cancer	0.000107	0.000346	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—pancreatic cancer	0.000106	0.000343	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—pancreatic cancer	0.000105	0.000343	CcSEcCtD
Efavirenz—Rash—Docetaxel—pancreatic cancer	0.000105	0.00034	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—pancreatic cancer	0.000104	0.000339	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—pancreatic cancer	0.000104	0.000339	CcSEcCtD
Efavirenz—Headache—Docetaxel—pancreatic cancer	0.000104	0.000338	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000102	0.000331	CcSEcCtD
Efavirenz—Shock—Doxorubicin—pancreatic cancer	0.000102	0.000331	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000101	0.00033	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000101	0.000329	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—pancreatic cancer	0.000101	0.000329	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—pancreatic cancer	0.000101	0.000328	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—pancreatic cancer	0.000101	0.000327	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—pancreatic cancer	0.0001	0.000326	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.0001	0.000325	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—pancreatic cancer	9.97e-05	0.000324	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—pancreatic cancer	9.94e-05	0.000323	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—pancreatic cancer	9.86e-05	0.00032	CcSEcCtD
Efavirenz—Nausea—Docetaxel—pancreatic cancer	9.85e-05	0.00032	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—pancreatic cancer	9.84e-05	0.00032	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—pancreatic cancer	9.72e-05	0.000316	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.66e-05	0.000314	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—pancreatic cancer	9.64e-05	0.000313	CcSEcCtD
Efavirenz—Constipation—Epirubicin—pancreatic cancer	9.56e-05	0.000311	CcSEcCtD
Efavirenz—Pain—Epirubicin—pancreatic cancer	9.56e-05	0.000311	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.43e-05	0.000306	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—pancreatic cancer	9.36e-05	0.000304	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—pancreatic cancer	9.29e-05	0.000302	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—pancreatic cancer	9.23e-05	0.0003	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—pancreatic cancer	9.22e-05	0.000299	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—pancreatic cancer	9.2e-05	0.000299	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.15e-05	0.000297	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—pancreatic cancer	9.11e-05	0.000296	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—pancreatic cancer	9e-05	0.000292	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.93e-05	0.00029	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—pancreatic cancer	8.92e-05	0.00029	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—pancreatic cancer	8.88e-05	0.000289	CcSEcCtD
Efavirenz—Pain—Doxorubicin—pancreatic cancer	8.85e-05	0.000288	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—pancreatic cancer	8.85e-05	0.000288	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—pancreatic cancer	8.84e-05	0.000287	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—pancreatic cancer	8.84e-05	0.000287	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—pancreatic cancer	8.53e-05	0.000277	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.46e-05	0.000275	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—pancreatic cancer	8.24e-05	0.000268	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—pancreatic cancer	8.22e-05	0.000267	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—pancreatic cancer	8.18e-05	0.000266	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—pancreatic cancer	8.18e-05	0.000266	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—pancreatic cancer	8.02e-05	0.000261	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—pancreatic cancer	7.91e-05	0.000257	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—pancreatic cancer	7.65e-05	0.000249	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—pancreatic cancer	7.62e-05	0.000248	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—pancreatic cancer	7.42e-05	0.000241	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—pancreatic cancer	7.4e-05	0.00024	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—pancreatic cancer	7.32e-05	0.000238	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—pancreatic cancer	7.11e-05	0.000231	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—pancreatic cancer	7.08e-05	0.00023	CcSEcCtD
Efavirenz—Rash—Epirubicin—pancreatic cancer	7.05e-05	0.000229	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—pancreatic cancer	7.05e-05	0.000229	CcSEcCtD
Efavirenz—Headache—Epirubicin—pancreatic cancer	7.01e-05	0.000228	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—pancreatic cancer	6.84e-05	0.000222	CcSEcCtD
Efavirenz—Nausea—Epirubicin—pancreatic cancer	6.64e-05	0.000216	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—pancreatic cancer	6.58e-05	0.000214	CcSEcCtD
Efavirenz—Rash—Doxorubicin—pancreatic cancer	6.52e-05	0.000212	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—pancreatic cancer	6.52e-05	0.000212	CcSEcCtD
Efavirenz—Headache—Doxorubicin—pancreatic cancer	6.48e-05	0.000211	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—pancreatic cancer	6.15e-05	0.0002	CcSEcCtD
